Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Indapta Therapeutics is a privately held biotechnology company.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
PepGen is empowering nucleic acid therapeutics to go the distance.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Metalex Commodities is a commodity trading company that specializes in the export of metal ores and concentrates.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Robotic microfactories for building net-zero homes 2x faster, 2x cheaper with 10x lower carbon
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Rani Therapeutics, Adcytherix, C4 Therapeutics, LEXEO Therapeutics, Adagio Medical. These companies were founded in 2020 or later.